factual

Derivatives Desk Pricing Revealed Biotech Investing Interest

Working on Merrill Lynch's derivatives desk, Karnal was assigned to biotech and found the life-or-death risk-reward setting compelling enough to pursue a career in life sciences investing.

factualpending

Speaker

Alex Karnal

Evidence Quote

“I actually never picked biotech. When I got moved over to the derivatives desk, I was just put into biotech.”

Source

Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]— Invest Like the Best
Created: 11/14/2026, 4:24:39 AM

Your notes

Loading notes...